Collegium Pharmaceutical, Inc.【COLL】業績推移・財務諸表

（単位：千ドル）	2Q15	3Q15	4Q15	1Q16	2Q16	3Q16	4Q16	1Q17	2Q17	3Q17	4Q17	1Q18	2Q18	3Q18	4Q18	1Q19	2Q19	3Q19	4Q19	1Q20	2Q20	3Q20	4Q20	1Q21	2Q21	3Q21	4Q21	1Q22	2Q22	3Q22	4Q22	1Q23	2Q23	3Q23	4Q23	1Q24	2Q24	3Q24	4Q24	1Q25	2Q25
売上高	-	-	-	-	-	408	1,303	2,172	3,560	11,950	10,794	63,749	73,061	70,176	73,427	74,516	75,040	72,942	74,203	76,511	78,058	79,176	76,271	87,721	82,942	78,843	27,362	83,751	123,549	127,013	129,620	144,767	135,546	136,709	149,745	144,923	145,276	159,301	181,949	177,757	188,000
売上成長率（％）	-	-	-	-	-	-	-	-	-
売上原価	-	-	-	-	-	29	184	371	577	553	1,094	43,106	46,838	46,007	29,726	49,164	48,654	46,754	49,088	37,524	29,694	30,983	31,979	32,123	32,703	32,730	28,695	35,255	71,185	68,174	79,831	67,365	61,720	56,398	55,115	53,467	54,470	62,507	83,661	80,433	79,616
売上総利益	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	38,987	48,364	48,193	44,292	55,598	50,239	46,113	-1,333	48,496	52,364	58,839	49,789	77,402	73,826	80,311	94,630	91,456	90,806	96,794	98,288	97,324	108,384
売上総利益率（％）	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
研究開発費	1,641	3,358	1,531	4,062	4,301	3,254	3,331	2,130	2,179	2,069	2,194	2,268	2,237	1,907	2,249	2,992	2,459	2,491	2,398	2,666	2,493	2,141	2,472	2,930	3,462	1,450	1,609	3,983	-	-	-	-	-	-	-	-	-	-	-	-	-
販売管理費	-	-	-	-	-	23,567	-	22,847	22,062	22,758	25,089	31,582	31,279	33,448	30,451	32,352	28,935	30,072	25,090	31,260	29,322	26,426	26,824	31,476	30,368	30,514	26,602	54,528	41,254	38,372	38,032	52,775	38,193	35,298	32,942	41,982	43,335	61,955	63,091	76,423	73,637
営業費用	4,575	9,265	9,436	15,587	24,474	26,850	28,882	25,348	24,818	25,380	28,377	76,956	80,354	81,362	62,426	84,508	80,048	79,317	76,576	33,926	31,815	28,567	29,296	34,406	33,830	31,964	32,789	58,511	41,254	38,372	38,032	52,775	38,193	35,298	32,942	41,982	43,335	61,955	60,177	75,637	73,279
営業利益	-4,575	-9,265	-9,436	-15,587	-24,474	-26,442	-27,579	-23,176	-21,258	-13,430	-17,583	-13,207	-7,293	-11,186	11,001	-9,992	-5,008	-6,375	-2,373	5,061	16,549	19,626	14,996	21,192	16,409	14,149	-34,122	-10,015	11,110	20,467	11,757	24,627	35,633	45,013	61,688	49,474	47,471	34,839	38,111	21,687	35,105
営業利益率 (%)	-	-	-	-	-
経常（税引前）利益	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8,304	11,566	7,262	15,474	10,991	9,037	-38,876	-15,842	-6,646	1,432	-7,791	-17,557	17,797	28,783	46,710	36,622	29,097	15,580	17,269	3,122	17,025
経常（税引前）利益率（％）	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10.64	14.61	9.52	17.64	13.25	11.46	-142.08	-18.92	-5.38	1.13	-6.01	-12.13	13.13	21.05	31.19	25.27	20.03	9.78	9.49	1.76	9.06
法人税等合計	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	246	280	304	-188	-61,852	991	-13,842	-2,773	-1,455	975	-592	-131	4,790	8,149	14,770	8,909	9,491	6,245	4,733	705	5,042
実効税率（％）	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
純利益	-4,674	-9,362	-9,525	-15,653	-24,520	-26,444	-27,559	-23,078	-21,121	-13,263	-17,403	-18,652	-13,060	-16,502	9,086	-9,700	-4,712	-6,109	-2,201	450	8,058	11,286	6,958	15,662	72,843	8,046	-25,034	-13,069	-5,191	457	-7,199	-17,426	13,007	20,634	31,940	27,713	19,606	9,335	12,536	2,417	11,983
純利益率（％）	-	-	-	-	-
一株あたり利益	-	-	-	-0.68	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.01	0.23	0.33	0.2	0.45	2.06	0.23	-0.73	-0.39	-0.15	0.01	-0.21	-0.51	0.38	0.61	0.99	0.86	0.6	0.29	0.39	0.08	0.38
希薄化後一株あたり利益	-	-	-	-0.68	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.01	0.23	0.32	0.2	0.41	1.79	0.22	-0.73	-0.39	-0.15	0.01	-0.21	-0.51	0.34	0.53	0.82	0.71	0.52	0.27	0.36	0.07	0.34
EBITDA	-	-	-		-	-	-		-	-	-	-	-	-	-		-	-	-		-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDAマージン（％）	-	-	-	-	-	-	-		-	-	-	-	-	-	-		-	-	-		-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Collegium Pharmaceutical, Inc.【COLL】 業績推移・財務諸表

Collegium Pharmaceutical, Inc.【COLL】業績推移・財務諸表